The Christ Hospital

Cardiac Dimensions Appoints Satya Shreenivas, MD as Chief Medical Officer

Retrieved on: 
Tuesday, January 16, 2024
Health, Medical Devices, Cardiology, Medpace, Patient, FMR, Tricuspid valve, MD, Multimedia, EMPOWER, Medical director, University, Heart failure, Cardiac catheterization, The Christ Hospital, MBA, Dimension, Christ Hospital, Mitral regurgitation, Medical device

Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.

Key Points: 
  • Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240116766817/en/
    Cardiac Dimensions' new Chief Medical Officer Satya Shreenivas, MD, MBA (Photo: Business Wire)
    Dr. Shreenivas brings his rich experience in both the clinical and commercial aspects of the structural heart landscape to his new role with Cardiac Dimensions.
  • His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.
  • Dr. Shreenivas has been instrumental in advising Cardiac Dimensions on its EMPOWER Trial of the Carillon Mitral Contour System®.

Lisata Therapeutics Announces First Patient Treated in the BOLSTER Trial of LSTA1, a Novel Tumor-Targeting and Penetrating Peptide, in Patients with Advanced Solid Tumors

Retrieved on: 
Tuesday, September 12, 2023
Cancer, Head, SOC, The Christ Hospital, Patient, Lymph, Throat, Therapy, Mouth, Cholangiocarcinoma, Pharmaceutical industry

BASKING RIDGE, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) --  Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced treatment of the first patient in the head and neck squamous cell carcinoma cohort of the BOLSTER trial, by Dr. Alexander N. Starodub, a principal investigator of the study, at The Christ Hospital in Cincinnati, Ohio.

Key Points: 
  • The BOLSTER trial is a basket trial being conducted at approximately 40 sites in North America, Europe, and Asia-Pacific.
  • Total trial enrollment of 120 patients is expected to be completed in the second half of 2024.
  • “We are excited to announce treatment of the first patient in the second-line head and neck squamous cell carcinoma cohort of the BOLSTER trial.
  • “Now that the first patient in BOLSTER has been treated, we expect an uptake in enrollment in the coming quarters.

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

NRC Health unveils winners of 2023 patient experience and loyalty awards

Retrieved on: 
Tuesday, August 8, 2023
New England Aquarium, New England, Success, Marital status, Mayo Clinic Hospital (Rochester), University, Beth Israel Deaconess Medical Center, National Research Corporation, Patient experience, NRC, Hospital, Health, Human, Sea, Organization, NPS, Hospital of the University of Pennsylvania, Missouri Baptist Medical Center, Community hospital, Monterey Peninsula, UC, The Christ Hospital, UC Davis Health Stadium, Patient, Lahey Hospital & Medical Center, California Hospital Medical Center, Christ Hospital, Parkview Health, Pharmaceutical industry, Nursing, Mercy, Troy

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

Key Points: 
  • LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.
  • NRC Health's Consumer Loyalty Award winners lead the way in delivering exceptional patient experiences.
  • Elevating the patient experience remains a priority in healthcare, and NRC Health's 2023 Excellence in Patient Experience Award winners have demonstrated outstanding commitment to individualized and human-centered care.
  • To check whether your local hospital is a 2023 honoree, see the full lists of winning organizations for both the 2023 Consumer Loyalty Awards and the 2023 Excellence in Patient Experience Awards .

Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG

Retrieved on: 
Thursday, April 13, 2023
Technology, Medical Devices, General Health, Hospitals, Science, Clinical Trials, FDA, Cardiology, Biotechnology, Health, Health Technology, Research, Other Technology, Audio, Video, Biometrics, Other Health, Radiology, MCG, Partnership, CMD, Dipyridamole, Hospital, Anatomy, Moyamoya disease, Principal investigator, Perception, Cardiovascular disease, European Society of Cardiology, Disease, History, Ischemia, Medical director, The Christ Hospital, Patient, Investment, Christ Hospital, Diagnosis, Education, European Society for Medical Oncology, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Breakthrough, Interventional cardiology, Food, Pharmaceutical industry, Medical device

Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its flagship imaging solution, CardioFlux MCG, to identify myocardial ischemia in patients who may be suffering from coronary microvascular disease (CMD).

Key Points: 
  • Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its flagship imaging solution, CardioFlux MCG, to identify myocardial ischemia in patients who may be suffering from coronary microvascular disease (CMD).
  • Annually, as many as 4 million patients in the United States alone are believed to present with diagnostic evidence of ischemia without evidence of obstructed coronary arteries, a condition broadly known as INOCA.
  • The FDA’s decision rested, in part, on the submission of preliminary findings from the MICRO trial, which attempted to demonstrate the use of non-invasive magnetocardiography (MCG) to diagnose myocardial ischemia in patients suspected to be suffering from CMD.
  • “Through various activities and investments, like our Women’s Heart Center, we’re making very real progress on that goal.

RIVERSIDE RADIOLOGY AND INTERVENTIONAL ASSOCIATES ANNOUNCE DAVID WEST, M.D., AS INCOMING PRACTICE PRESIDENT

Retrieved on: 
Tuesday, April 4, 2023
University, American Board of Radiology, Bellevue Hospital, Internal medicine, OH, Medicine, Trustee, Teaching hospital, American Board of Commissioners for Foreign Missions, Adrian Dixon, The Christ Hospital, Patient, University Hospital (Newark, New Jersey), Air force, American College, Radiological Society of North America, United States Department of the Air Force, Hospital, Medical imaging, Radiology, COLUMBUS

COLUMBUS, Ohio, April 4, 2023 /PRNewswire/ -- Riverside Radiology and Interventional Associates, Inc., a LucidHealth company, announces the appointment of David West, M.D., as incoming practice president of the largest radiology practice in the state of Ohio as of April 1, 2023. West, a board-certified diagnostic radiologist who studied at the University of Cincinnati and has practiced for nearly twenty-years, also specializes in vein related symptoms and diseases. He assumes the helm of leadership from Douglas Reader, M.D., who has served in the role since 2014.

Key Points: 
  • West succeeds Douglas Reader, M.D., as leader of the largest radiology practice in Ohio beginning April 1, 2023
    COLUMBUS, Ohio, April 4, 2023 /PRNewswire/ -- Riverside Radiology and Interventional Associates, Inc., a LucidHealth company, announces the appointment of David West, M.D., as incoming practice president of the largest radiology practice in the state of Ohio as of April 1, 2023.
  • He assumes the helm of leadership from Douglas Reader, M.D., who has served in the role since 2014.
  • "We are fortunate to have exemplary leadership throughout our entire practice," said Mark Alfonso, M.D., Chief Medical Officer of LucidHealth.
  • "It is a challenging, but also a very exciting time, to be in medicine and in radiology," remarked Asif Ahmed, CEO of LucidHealth.

Neovasc Announces Key Events at TCT 2022

Retrieved on: 
Thursday, September 8, 2022
Treatment, Piping and plumbing fitting, Chest pain, Muscle tissue, Convention center, Angina, Christ Hospital, NASDAQ, The Christ Hospital, Tel Aviv Sourasky Medical Center, Heart, Blood, Union, TSX, Innovation, Faculty, McMaster University, Boston Convention and Exhibition Center, GLOBE, Hospital, Company, Population, Perfusion, TCT, St. Francis Hospital, Adrenal insufficiency, Patient, Pharmaceutical industry, MD

VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX : NVCN ) today announced its participation and presence at the Transcatheter Cardiovascular Therapeutics TCT 2022 conference (TCT), hosted by the Cardiovascular Research Foundation (CRF), taking place in person at the Boston Convention & Exhibition Center, September 16-19, 2022.

Key Points: 
  • VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX : NVCN ) today announced its participation and presence at the Transcatheter Cardiovascular Therapeutics TCT 2022 conference (TCT), hosted by the Cardiovascular Research Foundation (CRF), taking place in person at the Boston Convention & Exhibition Center, September 16-19, 2022.
  • Members of the Neovasc team will be available at booth 647 in the exhibit hall.
  • For additional information and to register for TCT 2022, please visit: https://tct2022.crfconnect.com/ .
  • Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace.

NRC Health Unveils Winners of 2022 Annual Awards Programs

Retrieved on: 
Tuesday, August 16, 2022
NRC, Hospital, Clinical Excellence Awards, Industry, GLOBE, National Research Corporation, Mercy Health, California Hospital Medical Center, Hospital of the University of Pennsylvania, University of Utah Hospital, The Christ Hospital, Morristown Medical Center, Health, Nursing, NPS, Patient, Patient experience, Christ Hospital, Lahey Hospital & Medical Center, Trust, Mayo Clinic Hospital (Rochester), NASDAQ, Â, Organization, Lehigh Valley Health Network, Physician, Community hospital, University, Time, Monterey Peninsula, Pharmaceutical industry, Medicine, Health insurance, Pennsylvania Hospital

LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health, the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards, formerly known as the Excellence Awards. NRC Health’s loyalty-based hospital ranking recognizes the top 100 healthcare facilities, including the top 10 Best-In-Class winners, that are working to cultivate and maintain long-lasting loyalty among their patient populations. This year’s Excellence in Patient Experience honorees have been recognized for their efforts to consistently deliver outstanding patient experiences across the care continuum.

Key Points: 
  • LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards , formerly known as the Excellence Awards.
  • Winners of the NRC Health 2022 Excellence in Patient Experience Awards accomplished just that.
  • This years winners include Hawaii Pacific Health, Lehigh Valley Health Network, Mercy Health, and Northwest Community Healthcare as well as repeat winners from last year, Wabash General Hospital, Community Hospital of the Monterey Peninsula, Scottish Rite for Children and Tyron Medical Partners.
  • To see if your local hospital is a 2022 honoree, see the full lists of winning organizations for both the 2022 Consumer Loyalty Awards and the 2022 Excellence in Patient Experience Awards .

Two Cincinnati Internists Join MDVIP National Primary Care Network

Retrieved on: 
Wednesday, April 27, 2022
Health, Men's Health, MDVIP, Obesity, Twitter, Time, Degenerative disease, Science, Doctor of Philosophy, Concierge medicine, Fortune, The Christ Hospital, Patient, Goal, LinkedIn, Ipsos, Pharmacy, Biochemistry, Ohio State University College of Medicine, University college, Instagram, University of Cincinnati, Physician, University, Risk, Tri-state, Knowledge, Cardiovascular disease, Internal medicine, Fortis Healthcare, Medicine, Health insurance, Dentistry, Medicine, Health care, Facebook

BOCA RATON, Fla., April 27, 2022 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of 1,100 primary care physicians nationwide, today announced the opening of two new MDVIP-affiliated practices in Cincinnati, Ohio. Board-certified internists Edward Y. Chang, M.D., and David C. Fisher, M.D., are joining MDVIP to deliver patients a better healthcare experience with an emphasis on wellness and prevention. The two practices expand MDVIP's network footprint to 15 affiliated physicians in Cincinnati and 28 across the state of Ohio.

Key Points: 
  • The two practices expand MDVIP's network footprint to 15 affiliated physicians in Cincinnati and 28 across the state of Ohio.
  • MDVIP-affiliated physicians maintain significantly smaller practices, allowing them to spend more time with patients and provide more individualized primary care compared to traditional practices.
  • MDVIP leads the market in membership-based healthcare that goes far beyond concierge medicine services with a national network of approximately 1,100 primary care physicians serving 365,000 patients.
  • In response to growing consumer demand for a more personalized healthcare experience, hospital systems are incorporating the MDVIP model into their primary care offering.

Flow Therapy Adds World-Renowned Cardiologist Timothy D. Henry to Board of Directors

Retrieved on: 
Wednesday, April 6, 2022
Blood, LinkedIn, The Christ Hospital, Heart, SCAI, Heated humidified high-flow therapy, Leadership, University of California, Irvine Medical Center, Society, Board, EECP, Cardiology, Health care, Research, Cedars-Sinai Medical Center, External counterpulsation, FACC, Medical director, Board of directors, Oxygen, Quality of life, University, Carl, Chest pain, GLOBE, Degenerative disease, Awareness, STEMI, Fatigue, Heart failure, Patient, Angina, Hospital, Medical imaging, Pharmaceutical industry

FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) -- World-renowned cardiologist Timothy D. Henry,MD, FACC, MSCAI, has joined Flow Therapy's Board of Directors.

Key Points: 
  • FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) -- World-renowned cardiologist Timothy D. Henry,MD, FACC, MSCAI, has joined Flow Therapy's Board of Directors.
  • The addition of Dr. Henry to its Board demonstrates Flow Therapy's continued commitment to quality and experience as the organization builds its value-focused treatment program.
  • Flow Therapy continues to make scientific contributions to show the effectiveness of our EECP program in refractory angina patients.
  • We are grateful that Dr. Henry will be advising Flow Therapy,"saysFlow Therapy President Michael Gratch.